Neurotoxicity of MDMA: Main effects and mechanisms.
Costa G, Gołembiowska K.
Exp Neurol. 2022 Jan;347:113894. doi: 10.1016/j.expneurol.2021.113894. Epub 2021 Oct 13.
[Hallucinogenic mushrooms].
Reingardiene D, Vilcinskaite J, Lazauskas R.
Medicina (Kaunas). 2005;41(12):1067-70.
Hallucinogen Use Disorders.
Hardaway R, Schweitzer J, Suzuki J.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):489-96. doi: 10.1016/j.chc.2016.03.006. Epub 2016 Apr 18.
[Hallucinogen-induced psychological disorders].
Hermle L, Kovar KA, Hewer W, Ruchsow M.
Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191.
Neurological Effects of Stimulants and Hallucinogens.
Hass RM, Stitt D.
Semin Neurol. 2024 Aug;44(4):459-470. doi: 10.1055/s-0044-1787572. Epub 2024 Jun 18.
Is LSD toxic?
Nichols DE, Grob CS.
Forensic Sci Int. 2018 Mar;284:141-145. doi: 10.1016/j.forsciint.2018.01.006. Epub 2018 Feb 2.
Pheniramine as an hallucinogen.
Jones IH, Stevenson J, Jordan A, Connell HM, Hetherington HD, Gibney GN.
Med J Aust. 1973 Feb 24;1(8):382-6. doi: 10.5694/j.1326-5377.1973.tb118061.x.
[Phencyclidine--angel dust].
Høiseth G, Hjelmeland K, Bachs L.
Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2775-6.
[Ecstasy toxicity].
Reingardiene D.
Medicina (Kaunas). 2006;42(6):519-23.
Psychedelic mushroom-containing chocolate exposures: Case series.
Gartner HT, Wan HZ, Simmons RE, Sollee DR, Sheikh S.
Am J Emerg Med. 2024 Nov;85:208-213. doi: 10.1016/j.ajem.2024.09.038. Epub 2024 Sep 14.
